KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Inventory: 2010-2021

Historic Inventory for TherapeuticsMD (TXMD) over the last 12 years, with Dec 2021 value amounting to $7.6 million.

  • TherapeuticsMD's Inventory fell 8.98% to $6.7 million in Q3 2022 from the same period last year, while for Sep 2022 it was $6.7 million, marking a year-over-year decrease of 8.98%. This contributed to the annual value of $7.6 million for FY2021, which is 4.64% down from last year.
  • As of FY2021, TherapeuticsMD's Inventory stood at $7.6 million, which was down 4.64% from $8.0 million recorded in FY2020.
  • TherapeuticsMD's Inventory's 5-year high stood at $11.9 million during FY2019, with a 5-year trough of $1.5 million in FY2017.
  • Over the past 3 years, TherapeuticsMD's median Inventory value was $8.0 million (recorded in 2020), while the average stood at $9.2 million.
  • Per our database at Business Quant, TherapeuticsMD's Inventory surged by 262.97% in 2019 and then crashed by 32.61% in 2020.
  • Yearly analysis of 5 years shows TherapeuticsMD's Inventory stood at $1.5 million in 2017, then skyrocketed by 119.99% to $3.3 million in 2018, then soared by 262.97% to $11.9 million in 2019, then tumbled by 32.61% to $8.0 million in 2020, then declined by 4.64% to $7.6 million in 2021.